Loading...

For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin - Hallo friend HEALTHY LIVING, In the article you read this time with the title For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin, we have prepared well for this article you read and download the information therein. hopefully fill posts items ENTERTAINMENT, items FITNES, items HEALTHY, items HEALTHY FOOD, items HEALTHY LIVING, items HOW HEALTHY, we write this you can understand. Well, happy reading.

Title : For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin
link : For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin

For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin

That's a pretty big change:

Diabetes Guidelines Updated: For patients with type 2 diabetes who require an injectable drug, a glucagon-like peptide 1 receptor agonist is preferred over insulin. https://buff.ly/2T0Kowc

Glucagon-like peptide-1 (GLP-1)-based therapies (eg, GLP-1 receptor agonists, dipeptidyl peptidase-4 [DPP-4] inhibitors) affect glucose control through several mechanisms, including:

- enhancement of glucose-dependent insulin secretion
- slowed gastric emptying
- reduction of postprandial glucagon and food intake

These agents do not usually cause hypoglycemia.

Short-acting GLP-1 receptor agonists have an effect on postprandial hyperglycemia and gastric emptying:

- Exenatide twice daily. Exendin-4 is a naturally occurring component of the Gila monster lizard saliva and shares 53 percent sequence identity with GLP-1. Exenatide (half-life 2.4 hours) is synthetic exendin-4. Brand Names: Bydureon; Byetta Pen.

- Lixisenatide is a GLP-1 receptor agonist that shares some structural elements with exendin-4. Compared with native GLP-1, it has a prolonged half-life (2.7 to 4.3 hours). Brand Names: Adlyxin.

Long-acting GLP-1 receptor agonists have a greater resistance to dipeptidyl peptidase-4 (DPP-4) degradation. They activate the GLP-1 receptor continuously and have a prolonged half-life, thus allowing for once-daily and even once-weekly subcutaneous injection. They have a marked effect on fasting glucose.

- Exenatide once weekly is a sustained-release formulation of the short-acting subcutaneous exenatide.

- Liraglutide is GLP-1 receptor agonist which binds to serum albumin, resulting in slower degradation (half-life 11 to 15 hours) and allowing for once-daily, subcutaneous dosing. Brand Names: Saxenda; Victoza.

- Dulaglutide is a long-acting GLP-1 receptor agonist with structural modifications to prevent degradation by DPP-4 and to prolong its half-life. The half-life of dulaglutide is approximately five days, which allows for once-weekly administration. Brand Names: Trulicity/

- Semaglutide is a long-acting GLP-1 receptor agonist (94% homology with native human GLP-1) with structural modifications to reduce renal clearance and decrease degradation by DPP-4, resulting in half-life 155 to 184 hours, thus allowing for once-weekly, subcutaneous (or potentially once-daily, oral) dosing. Semaglutide is the only GLP-1 receptor agonist that has shown to be effective when given orally. Brand Names: Ozempic.

Based on studies, liraglutide or semaglutide are the preferred options.

The medications have a US Boxed Warning for Thyroid C-cell tumor risk.

References:

https://www.jwatch.org/fw114893/2018/12/19/diabetes-guidelines-updated
http://care.diabetesjournals.org/content/42/Supplement_1
https://www.uptodate.com/contents/glucagon-like-peptide-1-receptor-agonists-for-the-treatment-of-type-2-diabetes-mellitus

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.

via CasesBlog - Medical and Health Blog More READ

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Loading...

thus Article For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin

that is all articles For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin This time, hopefully can provide benefits to all of you. Okay, see you in another article posting.

You now read the article For type 2 diabetes patients who require an injectable drug, GLP-1-based drugs are preferred over insulin with the link address https://healthylivingsimple.blogspot.com/2018/12/for-type-2-diabetes-patients-who.html

Tweet

Subscribe to receive free email updates: